Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 5
272
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Association of Polymorphisms in Cytokine genes with susceptibility to Precancerous Lesions and Cervical Cancer: A systematic review with meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all

References

  • ACMdos S, de Moura EL, Ferreira JM, Santos BRCD, Alves VDM, de Farias KF, de Souza Figueiredo EVM. 2017. Meta-analysis of the relationship between TNF-α (−308G/A) and IL-10 (−819C/T) gene polymorphisms and susceptibility to Dengue. Immunol Invest. 46(2):201–20.
  • Badano I, Stietz SM, Schurr TG, Picconi AM, Fekete D, Quintero IM, Cabrera MDE, Campos RH, Liotta JD. 2012. Analysis of TNFα promoter SNPs and the risk of cervical cancer in urban populations of Posadas (Misiones, Argentina). J. Clin Virol. 53(1):54–59.
  • Barbisan G, Pérez LO, Contreras A, Golijow CD. 2012. TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol. 33(5):1549–56.
  • Bermúdez-Morales VH, Fierros-Zarate G, García-Meléndrez C, Alcocer-Gonzalez JM, Morales-Ortega A, Peralta-Zaragoza O, Torres-Poveda K, Burguete-García AI, Hernández-Márquez E, Madrid-Marina V. 2016. In vivo antitumor effect of an HPV-specific promoter driving IL-12 expression in an HPV 16-positive murine model of cervical cancer. J Cancer. 7(14):1950.
  • Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, Gostout BS, Persing DH. 2002. Host genetic polymorphism analysis in cervical cancer. Clin Chem. 48(8):1218–24.
  • Castellsagué X, Bosch FX, Muñoz N. 2002. Environmental co-factors in HPV carcinogenesis. Virus Res. 89(2):191–99.
  • Castro FA, Haimila K, Sareneva I, Schmitt M, Lorenzo J, Kunkel N, Kumar R, Försti A, Kjellberg L, Hallmans G, et al. 2009. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population-A candidate gene approach. Int J Cancer. 125(8):1851–58.
  • Chagas BS, Gurgel APAD, HLA DC, Amaral CMM, M V C, Neto JDCS, Silva LAFD, Albuquerque EMBD, Muniz MTC, Freitas ACD. 2013. An interleukin-10 gene polymorphism associated with the development of cervical lesions in women infected with Human Papillomavirus and using oral contraceptives. Infect Genet Evol. 19:32–37.
  • Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, et al. 2006. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet. 15(4):519–29.
  • Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, Shi X, Qian N, Wang X, Wei Q, et al. 2009. Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res. 15(1):400–05.
  • Chinchai T, Homchan K, Sopipong W, Chansaenroj J, Swangvaree S, Junyangdikul P, Vongpunsawad S, Poovorawan Y. 2016. Lack of Associations between TNF-αPolymorphisms and Cervical Cancer in Thai women. Asian Pac J Cancer Prev. 17(3):953–56.
  • Chuang M-J, Sun K-H, Tang S-J, Deng M-W, Wu Y-H, Sung J-S, Cha T-L, Sun G-H. 2008. Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. Cancer Sci. 99(5):905–13.
  • Cong J, Liu R, Wang X, Sheng L, Jiang H, Wang W, Zhang Y, Yang S, Li C. 2015. Association between interleukin-17 gene polymorphisms and the risk of cervical cancer in a Chinese population. Int J Clin Exp Pathol. 8(8):9567–73.
  • da Silva RC, da Cruz HLA, LAC B, Guimarães RL, Montenegro LML, Schindler HC, Segat L, Crovella S. 2016. DEFB1 gene polymorphisms and tuberculosis in a Northeastern Brazilian population. Brazilian J Microbiol. 47(2):389–93.
  • Das CR, Tiwari D, Dongre A, Khan MA, Husain SA, Sarma A, Bose S, Bose PD. 2018. Deregulated TNF-Alpha Levels Along with HPV Genotype 16 Infection are associated with pathogenesis of Cervical Neoplasia in Northeast Indian Patients. Viral Immunol. 31(4):282–91.
  • De Carvalho VDCV, De Macêdo JL, De Lima CAD, De Lima MDCG, De Andrade Heráclio S, Amorim M, De Mascena Diniz Maia M, Figueiredo Porto AL, Eleutério De Souza PR. 2012. IFN-gamma and IL-12B polymorphisms in women with cervical intraepithelial neoplasia caused by human papillomavirus. Mol Biol Rep. 39(7):7627–34.
  • de Lima Júnior SF, Tavares MMF, de Macedo JL, de Oliveira RS, Heráclio SDA, Maia MDMD, de Souza PRE, Moura R, Crovella S. 2016. Influence of IL-6, IL-8, and TGF-β1 gene polymorphisms on the risk of human papillomavirus-infection in women from Pernambuco, Brazil. Mem Inst Oswaldo Cruz. 111(11):663–69.
  • de Souza NCN, Brenna SMF, Campos F, Syrjanen KJ, Baracat EC, Silva I. 2006. Interleukin-6 polymorphisms and the risk of cervical cancer. Int J Gynecol Cancer. 16(3):1278–82.
  • DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials. 7(3):177–88.
  • Ding B, Fu S, Wang M, Yue C, Wang W, Zhou D, Zhang Z, Han S. 2012. Tumor necrosis factor α −308 G>A polymorphisms and cervical cancer risk: A meta-analysis. Int J Gynecol Cancer. 22(2):213–19.
  • Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, Pereira D, Moutinho J, Canedo P, MacHado JC, et al. 2005. G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun. 334(2):588–92.
  • Dutta S, Chakraborty C, Mandal RK, Basu P, Biswas J, Roychoudhury S, Panda CK. 2015. Persistent HPV16/18 infection in Indian women with the A-allele (rs6457617) of HLA DQB1 and T-allele (rs16944) of IL−1β 511 is associated with development of cervical carcinoma. Cancer Immunol Immunother. 64(7):843–51.
  • Egger M, Smith GD, Phillips AN. 1997. Meta-analysis: Principles and procedures. BMJ. 315(7121):1533–37.
  • El-Omar EM, Carrington M, Chow WH, KEL M, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, et al. 2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 404(6776):398–402.
  • Elsayed HM, Nabiel Y, Sheta T. 2017. IL12 Gene Polymorphism in association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients. Immunol Invest. 46(2):123–33.
  • Eskdale J, Kube D, Tesch H, Gallagher G. 1997. Mapping of the human IL10 gene and further characterization of the 5ʹ flanking sequence. Immunogenetics. 46(2):120–28.
  • Espinoza JL, Takami A, Nakata K, Onizuka M, Kawase T, Akiyama H, Miyamura K, Morishima Y, Fukuda T, Kodera Y, et al. 2011. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One. 6:10.
  • Farzaneh F, Roberts S, Mandal D, Ollier B, Winters U, Kitchener HC, Brabin L. 2006. The IL-10-1082G polymorphism is associated with clearance of HPV infection. BJOG. 113(8):961–64.
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2015. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136(5):E359–E386.
  • Fishman D, Faulds G, Jeffey R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic- onset juvenile chronic arthritis. J Clin Invest. 102(7):1369–76.
  • Govan VA, Carrara HRO, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL. 2003. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog. 2:1–8.
  • Govan VA, Constant D, Hoffman M, Williamson A-L. 2006. The allelic distribution of −308 Tumor Necrosis factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer. 6:24.
  • Guo C, Wen L, Song J-K, Zeng W-J, Dan C, Niu Y-M, Shen M. 2018. Significant association between interleukin-10 gene polymorphisms and cervical cancer risk: A meta-analysis. Oncotarget. 9(15):12365.
  • Han SS, Cho EY, Lee TS, Kim JW, Park NH, Song YS, Kim JG, Lee HP, Kang SB. 2008. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical caner in Korean women. Eur J Obstet Gynecol Reprod Biol. 140(1):71–75.
  • Hayashi R, Tahara T, Shiroeda H, Saito T, Nakamura M, Tsutsumi M, Shibata T, Arisawa T. 2013. Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis. Clin Exp Med. 13(4):239–44.
  • He Y, Du Y, Wei S, Shi J, Mei Z, Qian L, Chen Z, Jie Z. 2017. IL-17A and IL-17F single nucleotide polymorphisms associated with lung cancer in Chinese population. Clin Respir J. 11(2):230–42.
  • Higgins JPT, Thompson SG. 2002. Quantifying heterogeneity in a meta-analysis. Stat Med. 21(11):1539–58.
  • Higgins JPT, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ Br Med J. 327(7414):557–60.
  • Horita N, Kaneko T. 2015. Genetic model selection for a case-control study and a meta-analysis. Meta Gene. 5:1–8.
  • Ivansson EL, Gustavsson IM, Magnusson JJ, Steiner LL, Magnusson PKE, Erlich HA, Gyllensten UB. 2007. Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer. 121(11):2451–57.
  • Ivansson EL, Juko-Pecirep I, Gyllensten UB. 2010. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol. 116(3):544–48.
  • Jin Y. 2014. Association of single nucleotide polymorphisms in Tumor Necrosis factor-Alpha with Cervical Cancer susceptibility. Cell Biochem Biophys. 71(1):77–84.
  • Kang S, Kim JW, Park NH, Song YS, Park SY, Kang SB, Lee HP. 2007. Interleukin-1 beta-511 polymorphism and risk of cervical cancer. J Korean Med Sci. 22(1):110–13.
  • Kastelein RA, Hunter CA, Cua DJ. 2007. Discovery and Biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu Rev Immunol. 25:221–42.
  • Kim JW, Roh JW, Park NH, Song YS, Kang SB, Lee HP. 2003. Interferon, alpha 17 (IFNA17) Ile184Arg polymorphism and cervical cancer risk. Cancer Lett. 189(2):183–88.
  • Kordi Tamandani DM, Shekari M, Suri V. 2009. Interleukin-12 gene polymorphism and cervical cancer risk. Am J Clin Oncol Cancer Clin Trials. 32(5):524–28.
  • Kordi Tamandani MK, Sobti RC, Shekari M, Mukesh M, Suri V. 2008. Expression and polymorphism of IFN-gamma gene in patients with cervical cancer. Exp Oncol. 30(3):224–29.
  • Kumar S, Ambrosini G, Bucher P. 2017. SNP2TFBS-a database of regulatory SNPs affecting predicted transcription factor binding site affinity. Nucleic Acids Res. 45(D1):D139–D144.
  • Li H, Tian J, Cheng H, Zhang H, Zhang D. 2016. Association of tumor necrosis factor alpha polymorphisms with cervical cancer in a Chinese population. Int J Clin Exp Pathol. 9(2):2200–07.
  • Li L, Tian YL, Lv XM, Yu HF, Xie YY, Wang JD, Shi W. 2015. Association analysis of IL-17A and IL-17F polymorphisms in Chinese women with cervical cancer. Genet Mol Res. 14(4):12178–83.
  • Liu L, Yang X, Chen X, Kan T, Shen Y, Chen Z, Hu Z. 2012. Association between TNF-α polymorphisms and cervical cancer risk: A meta-analysis. Mol Biol Rep. 39(3):2683–88.
  • Lv Q, Zhu D, Zhang J, Yi Y, Yang S, Zhang W. 2015. Association between six genetic variants of IL-17A and IL-17F and cervical cancer risk: A case–control study. Tumor Biol. 36(5):3979–84.
  • Marangon AV, Guelsin GAS, Visentainer JEL, Borelli SD, Watanabe MAE, Consolaro MEL, Caleffi-Ferracioli KR, Rudnick CCC, Sell AM, Caleffi-Ferracioli KR, et al. 2013. The association of the immune response genes to Human Papillomavirus-related cervical disease in a Brazilian population. Biomed Res Int. 2013:1–11.
  • Mareti Bonin C, Zatorre Almeida-Lugo L, Dos Santos AR, Padovani TCJ, AM, Dos Santos Fernandes CE, Resende J, Bovo AC, Tozetti IA. 2019. Interleukin-17 expression in the serum and exfoliated cervical cells of patients infected with high-risk oncogenic human papillomavirus. Cytokine. 120:92–98.
  • Matsumoto K, Oki A, Satoh T, Okada S, Minaguchi T, Onuki M, Ochi H, Nakao S, Sakurai M, Abe A, et al. 2010. Interleukin-10-1082 Gene Polymorphism and susceptibility to cervical cancer among Japanese Women. Jpn J Clin Oncol. 40(11):1113–16.
  • Mayadev J, Lim J, Durbin-Johnson B, Valicenti R, Alvarez E. 2018. Smoking decreases survival in locally advanced cervical cancer treated with radiation. Am J Clin Oncol Cancer Clin Trials. 41(3):295–301.
  • Miranda LN, Reginaldo FPS, Souza DMBO, Soares CP, Silva TGA, Rocha KBF, Jatobá CAN, Donadi EA, Andrade JML, Gonçalves AKS, et al. 2014. Greater expression of the human leukocyte antigen-G (HLA-G) and interleukin-17 (IL-17) in cervical intraepithelial neoplasia: analytical cross-sectional study. Sao Paulo Med J. 133(4):336–42.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med. 151(4):264–69.
  • Nagai Y, Maehama T, Asato T, Kanazawa K. 2001. Detection of human papillomavirus DNA in primary and metastatic lesions of carcinoma of the cervix in women from Okinawa, Japan. Am J Clin Oncol Cancer Clin Trials. 24(2):160–66.
  • Ni J, Ye Y, Teng F, Wu Q. 2013. Interleukin 10 polymorphisms and cervical cancer risk: A meta-analysis. Int J Gynecol Cancer. 23(1):126–33.
  • Nicodemus KK. 2008. Catmap: case-control and TDT meta-analysis package. BMC Bioinformatics. 9(1):130.
  • Nieves-Ramirez ME, Partida-Rodriguez O, Alegre-Crespo PE, Del C Tapia-Lugo M, Perez-Rodriguez ME. 2011. Characterization of single-nucleotide polymorphisms in the Tumor Necrosis factor α promoter region and in Lymphotoxin α in Squamous Intraepithelial Lesions, precursors of Cervical Cancer. Transl Oncol. 4(6):336–44.
  • Pan F, Tian J, Ji C-S, He Y-F, Han X-H, Wang Y, Du J-P, Jiang F-S, Zhang Y, Y-Y P, et al. 2012. Association of TNF-α-308 and −238 polymorphisms with risk of Cervical Cancer: A meta-analysis. Asian Pacific J Cancer Prev. 13(11):5777–83.
  • Paradkar PH, Joshi JV, Mertia PN, Agashe SV, Vaidya RA. 2014. Role of cytokines in genesis, progression and prognosis of Cervical Cancer. Asian Pacific J Cancer Prev. 15(9):3851–64.
  • Paradkar PH, S V A, J V J, Jagtap SS, Affandi MZ, Vaidya RA. 2010. Serum IL-6 and micrometry of pap smears in women with cervical low-grade intraepithelial lesions. Asian Pac J Cancer Prev. 11(4):989–92.
  • Qian N, Chen X, Han S, Qiang F, Jin G, Zhou X, Dong J, Wang X, Shen H, Hu Z. 2010. Circulating IL-1β levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women. J Cancer Res Clin Oncol. 136(5):709–16.
  • Roszak A, Mostowska A, Sowińska A, Lianeri M, Jagodziński PP. 2012. Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer. Pathol Oncol Res. 18(4):997–1002.
  • Santos CMDC, Pimenta CADM, Nobre MRC. 2007. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Rev Latino-am Enferm. 15(3):2–5.
  • Shekari M, Kordi-Tamandani DM, MalekZadeh K, Sobti RC, Karimi S, Suri V. 2012. Effect of anti-inflammatory (IL-4, IL-10) Cytokine Genes in relation to risk of Cervical Carcinoma. Am J Clin Oncol. 35(6):514–19.
  • Shi J, Yuan M, Liu S, Duan X, Chen J. 2016. Correlation of IL-27 genetic polymorphisms with the risk and survival of cervical cancer in a Chinese Han population. Tumor Biol. 37(5):6875–79.
  • Shi TY, Zhu ML, He J, Wang MY, Li QX, Zhou XY, Sun MH, Shao ZM, Yu K Da, Cheng X, et al. 2013. Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women. Hum Genet. 132(3):301–12.
  • Shi W-J, Liu H, Wu D, Tang Z-H, Shen Y-C, Guo L. 2014. Stratification analysis and case-control study of relationships between interleukin-6 gene polymorphisms and cervical cancer risk in a Chinese population. Asian Pacific J Cancer Prev. 15(17):7357–62.
  • Si FZ, Feng YQ, Han M. 2017. Association between interleukin-17 gene polymorphisms and the risk of laryngeal cancer in a Chinese population. Genet Mol Res. 16(1):9567–73.
  • Singh H, Jain M, Sachan R, Mittal B. 2009. Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer. 19(7):1190–94.
  • Singhal P, Kumar A, Bharadwaj S, Hussain S, Bharadwaj M. 2015. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma. Tumor Biol. 36(4):2287–98.
  • Stanczuk GA, Sibanda EN, Perrey C, Chirara M, Pravica V, Hutchinson IV, Tswana SA. 2001. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer. 94(6):792–94.
  • Stang A. 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 25(9):603–05.
  • Sun LX, Wang XB, Huang XJ. 2015a. Association analysis of rs2275913 G>A and rs763780 T>C interleukin 17 polymorphisms in Chinese women with cervical cancer. Genet Mol Res. 14(4):13612–17.
  • Sun R, Jia F, Liang Y, Li L, Bai P, Yuan F, Gao L, Zhang L. 2015b. Interaction analysis of IL-12A and IL-12B polymorphisms with the risk of colorectal cancer. Tumor Biol. 36(12):9295–301.
  • Tacconelli E. 2010. Systematic reviews: CRD’s guidance for undertaking reviews in health care. Lancet Infect Dis. 10(4):226.
  • Tao Y-P, Wang W-L, Li S-Y, Zhang J, Shi Q-Z, Zhao F, Zhao B-S. 2012. Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer. J Cancer Res Clin Oncol. 138(11):1891–900.
  • Tavares MCM, de Lima Júnior SF, Coelho AVC, Marques TRNM, de Araújo DHT, Heráclio S de A, Amorim MMR, de Souza PRE, Crovella S. 2016. Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion. Ann Hum Biol. 43(3):261–68.
  • Torres-Poveda K, Burguete-García AI, Bahena-Román M, Méndez-Martínez R, Zurita-Díaz MA, López-Estrada G, Delgado-Romero K, Peralta-Zaragoza O, Bermúdez-Morales VH, Cantú D, et al. 2016. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: A case control study. BMC Cancer. 16(1):330.
  • von Linsingen R, Bompeixe EP, Maestri CA, Carvalho NS, Bicalho MDG. 2009. IFNG (+874 T/A) Polymorphism and Cervical Intraepithelial Neoplasia in Brazilian Women. J Interf Cytokine Res. 29(5):285–88.
  • Wang J, Nong L, Wei Y, Qin S, Zhou Y, Tang Y. 2013. Association of Interleukin-12 Polymorphisms and Serum IL-12p40 Levels with Osteosarcoma Risk. DNA Cell Biol. 32(10):605–10.
  • Wang L, Jiang Y, Zhang Y, Wang Y, Huang S, Wang Z, Tian B, Yang Y, Jiang W, Pang D. 2012a. Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han Women with Breast Cancer. Medeiros R. editor. PLoS One. 73:e34400 10.1371/journal.pone.0034400.
  • Wang L, Du F, Wang X. 2008. TNF-α induces two distinct Caspase-8 activation pathways. Cell. 133(4):693–703.
  • Wang L, Ma K, Wang Z, Mou Y, Ma L, Guo Y. 2015. Association between tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical cancer. Int J Clin Exp Med. 8(2):2108–17.
  • Wang N, Yin D, Zhang S, Wei H, Wang S, Yang Z, Lu Y, Dai S, Li W, Zhang Q, et al. 2012b. TNF-Alpha rs1800629 polymorphism is not associated with HPV Infection or Cervical Cancer in the Chinese population. PLoS One. 7(9):e45246.
  • Wang Q, Zhang C, Walayat S, Chen HW, Wang Y. 2011. Association between cytokine gene polymorphisms and cervical cancer in a Chinese population. Eur J Obstet Gynecol Reprod Biol. 158(2):330–33.
  • Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. 1997. Effects of a polymorphism in the human tumor necrosis factor promoter on transcriptional activation. Proc Natl Acad Sci. 94(7):3195–99.
  • Yang B, Kang H, Fung A, Zhao H, Wang T, Ma D. 2014. The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. Mediators Inflamm. 2012:623759.
  • Yang L-J, Gao W, Bai J-Y, Zhang X-K, Han X, Sun Y-H, Zhang -L-L, Zhang -M-M. 2016. Correlation between Interleukin-17 gene polymorphism and gastric cancer susceptibility in Han Chinese population. Eur Rev Med Pharmacol Sci. 20(7):1271–82.
  • Yang S, Li C, Li X, Huang X, Zhao Q, Liu D, Wu S. 2017. Relationship of IL-17A and IL-17F genetic variations to cervical cancer risk: A meta-analysis. Biomark Med. 11(5):459–71.
  • Yang Y-C, Chang T-Y, Chen T-C, Chang S-C, Lin W-S, Lee Y-J. 2013. Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma. Hum Immunol. 74(7):882–87.
  • Yin G, Zhu T, Li J, Wu A, Liang J, Zhi Y. 2015. CXCL12 rs266085 and TNF-α rs1799724 polymorphisms and susceptibility to cervical cancer in a Chinese population. Int J Clin Exp Pathol. 8(5):5768–74.
  • Yuan Y, Fan J, Yao F, Wang K, Yu Y, Carlson J, Li M. 2015. Association study of single-nucleotide polymorphisms of STAT2/STAT3/IFN-γ genes in cervical cancer in Southern Chinese Han Women. Asian Pacific J Cancer Prev. 16(8):3117–20.
  • Zhang HL, Zhang YJ. 2013. A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer. Tumor Biol. 34(3):1659–65.
  • Zhang S, Kong YL, Li YL, Yin YW. 2014. Interleukin-10 gene –1082 G/A polymorphism in cervical cancer and cervical intraepithelial neoplasia: Meta-analysis. J Int Med Res. 42(6):1193–201.
  • Zhou F, Qiu L-X, Cheng L, Wang M-Y, Li J, Sun M-H, Yang Y-J, Wang J-C, Jin L, Wang Y-N, et al. 2016. Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population. Oncotarget. 7(50):82384.
  • Zoodsma M, Nolte IM, Schipper M, Oosterom E, Van Der Steege G, De Vries EGE, Te Meerman GJ, Van Der Zee AGJ. 2005. Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int J Gynecol Cancer. 15(6 SUPPL. 3):282–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.